Global Gene Editing Tools Market Report 2024: A $3.83 Billion Market by 2034, with a CAGR of 18.84% During 2024-2034
May 27, 2024 04:13 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Gene Editing Tools Market" report has been added to ResearchAndMarkets.com's offering.The global gene editing tools market accounted for USD...
Global Cell Therapy and Gene Therapy Market Report 2023-2029
May 13, 2024 11:34 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029" report has been added to ResearchAndMarkets.com's offering.A newly released...
Gene Editing Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 354 Agreements Signed Since 2016
May 07, 2024 07:38 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Gene Editing Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Gene Editing Collaboration and...
Molecular Biology Enzymes And Kits And Reagents Market Surges to USD 69.4 Billion by 2031, Propelled by 17.35% CAGR - Verified Market Research®
May 02, 2024 10:00 ET
|
Verified Market Research
Lewes, Delaware, May 02, 2024 (GLOBE NEWSWIRE) -- The Global Molecular Biology Enzymes And Kits And Reagents Market is projected to grow at a CAGR of 17.35% from 2024 to 2031, according to a new...
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
May 02, 2024 06:30 ET
|
Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb
April 03, 2024 03:10 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering. The Global Cell and Gene Therapy Market is...
Asia-Pacific Gene Editing Technology Research Report 2024
February 29, 2024 10:03 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The...
Europe's Gene Editing Technologies Market, Valued at $370 Million in 2023, is Set to Reach $3.26 Billion by 2032 - Country-Specific Insights for Agriculture & Biomedical Applications Unveiled
January 30, 2024 07:50 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe gene...
Expert report details the scientific and regulatory challenges of genetic pest-control technologies
November 08, 2023 06:00 ET
|
The Council of Canadian Academies (CCA)
Ottawa, ON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Gene-editing technologies hold promising applications for pest control, but pose critical risk-management issues, according to Framing Challenges and...